Kulvinder Kochar Kaur, MD, et al. “Improved Management of Type 2 Diabetes Mellitus With Empigliflozin and Hypertension With Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes”. Obesity Research, Jan. 2025, pp. 1-13, doi:10.17140/oroj.2025.v11.i01.pp01-13.1425.